2022 年第 4 期 第 17 卷

天智颗粒治疗轻/中度血管性痴呆伴肝阳上亢证临床应用专家共识（2021年版）

Expert consensus on clinical application of Tianzhi granules in the treatment of mild/moderate vascular dementia with hyperactivity of liver-Yang syndrome (2021 edition) 

作者：北京神经内科学会

英文作者：Beijing Neurology Association

单位：北京神经内科学会

英文单位：Beijing Neurology Association

关键词：血管性痴呆；天智颗粒；肝阳上亢证

英文关键词：Vasculardementia；Tianzhigranules；Hyperactivityofliver-Yangsyndrome

• 摘要：

• 血管性痴呆是血管病变的严重后果之一，也是认知障碍领域中科研与临床工作的重点。经过多年科学研究和临床实践，积累了诸多关于天智颗粒治疗血管性痴呆的循证医学证据，不仅被多项指南及共识推荐，同时也成为本共识的基础及内容。本共识旨在总结天智颗粒前期研究成果，对天智颗粒在认知障碍领域规范使用提供理论支持和具体临床应用建议。 i-language:EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'>上亢证临床应用专家共识（2021年版）

• Vascular dementia is one of the serious consequences of vascular disease. It is also the focus of scientific research and clinical work in the field of cognitive impairment. After years of scientific research and clinical practice, a lot of evidence-based medical evidences on the treatment of vascular dementia by Tianzhi granules have been accumulated, which have not only been recommended by a number of guidelines and consensus, but also becomes the basis and content of this consensus. This consensus aims to summarize the previous research achievements of Tianzhi granules and to provide theoretical support and specific clinical suggestions on the standard of Tianzhi granules in cognitive impairment. n;mso-fareast-font-family:宋体;mso-fareast-theme-font: minor-fareast;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:minor-bidi;mso-ansi-language:EN-US;mso-fareast-language: ZH-CN;mso-bidi-language:AR-SA'>2021年版）